Ketorolac Tromethamine Injection — FDA Drug Shortage

Current — Baxter Healthcare

The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Baxter Healthcare with status Current. The shortage was first posted on Jun 6, 2018.

Shortage details

Status
Current
Company
Baxter Healthcare
Package NDC
0338-0072-25
Dosage Form
Injection
Presentation
Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)
Initial Posting
Jun 6, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.